Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060936) titled 'Usefulness of GLP-1 receptor agonists in patients with type 2 diabetes who are receiving antipsychotic therapy and have obesity or fatty liver' on April 1.
Study Type:
Observational
Primary Sponsor:
Institute - Osaka Prefectural Hospital Organization Osaka Psychiatric Medical Center
Condition:
Condition - Patients with type 2 diabetes who are receiving antipsychotic therapy and have obesity or fatty liver
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - to clarify the usefulness of GLP-1 receptor agonists in patients with type 2 diabetes who are receiving antipsych...